Aptose Biosciences Inc.
APTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $30,019 | $514,731 | $802,723 | $1,803,293 |
| - Cash | $6,152 | $9,252 | $36,970 | $39,114 |
| + Debt | $10,639 | $1,015 | $1,303 | $574 |
| Enterprise Value | $34,506 | $506,494 | $767,056 | $1,764,753 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$475 | -$507 | -$617 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$52,268 | -$42,482 | -$65,297 |
| % Margin | – | – | – | – |
| Net Income | -$25,430 | -$51,207 | -$41,823 | -$65,354 |
| % Margin | – | – | – | – |
| EPS Diluted | -18.94 | -27.08 | -22.12 | -34.56 |
| % Growth | 30.1% | -22.4% | 36% | – |
| Operating Cash Flow | -$35,977 | -$44,590 | -$32,322 | -$43,304 |
| Capital Expenditures | -$5 | -$29 | -$24 | -$212 |
| Free Cash Flow | -$35,982 | -$44,619 | -$32,346 | -$43,516 |